Alyssa Nicole Grant, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 420 W High St, Dowagiac, MI 49047 Phone: 269-783-3041 |
Erin Stauffer, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 55432 Colby St, Dowagiac, MI 49047 Phone: 269-782-7828 |
Michael James Mclaughlin Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 29588 Peavine St, Dowagiac, MI 49047 Phone: 269-240-4028 |
Julie Ann Macyauski Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 55432 Colby St, Dowagiac, MI 49047 Phone: 269-782-7828 |
News Archive
Patients with liver failure could benefit from a treatment that helps the immune system to combat infections linked to the condition, research suggests.
Materials science and the pharmaceutical industry could soon be revolutionized by emerging nanotechnologies based on designer molecules with long complex tree-and branch structures. Such molecules offer almost limitless scope for design of bespoke compounds for specific applications in disease therapy, for novel materials such as resins, as well as electronic displays, and energy storage. Almost every field involving design and synthesis of chemical compounds will be transformed by the arrival of technologies allowing nanoscale design of these branched molecules, known as hyperbranched polymers.
The American Pain Foundation today announced the launch of PainSAFE (Pain Safety & Access For Everyone), a new educational initiative designed for people with pain and health care professionals. The mission of PainSAFE is to provide education surrounding the appropriate and safe use of pain management therapies for people affected by pain and health care professionals, thereby, helping to reduce risk and improve access to quality pain care.
Texas A&M University College of Medicine ressearchers have recently discovered that cytisine - a smoking cessation drug commonly used in Europe - reduces the loss of dopamine neurons in females. These findings provide potential evidence for the use of the drug to treat Parkinson's disease or stop its progression in women.
Lee Wetzler, MD, an attending physician in the department of infectious diseases at Boston Medical Center and associate program director for research in the section of infectious diseases at Boston University School of Medicine (BUSM), was awarded a four-year, $2.35 million grant from the National Institutes of Health (NIH) to study the development of a gonococcal vaccine.
› Verified 4 days ago